Ontrak (Ontrak) GF Value : $0.91 (As of May. 03, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Ontrak GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-03), Ontrak's share price is $0.2646. Ontrak's GF Value is $0.91. Therefore, Ontrak's Price-to-GF-Value for today is 0.29.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Ontrak is Possible Value Trap, Think Twice.

Ontrak (NAS:OTRK) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Ontrak's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.2646	/	0.91
	=	0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ontrak GF Value Related Terms

Thank you for viewing the detailed overview of Ontrak's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ontrak (Ontrak) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

OTRKP.PFD:USA HY10:Germany HY10:Germany

Address

2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052

Website

https://www.ontrakhealth.com

Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.

Executives

Judith Feld	officer: Chief Medical Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina	director	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill	officer: Chief Information Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino	officer: Chief Medical Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne	officer: Chief Customer Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park	officer: Chief Accounting Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew	officer: Chief Executive Officer	ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer	director, 10 percent owner, officer: CEO	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton	officer: General Counsel and Secretary	1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn	director	US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak	director	2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros	officer: Chief Operating Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne	officer: Chief Financial Officer	1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith	10 percent owner	888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo	director	2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404